Catheter Precision

Catheter Precision Quick Ratio

The Quick Ratio (Acid Test) of Catheter Precision (VTAK) as of Oct 21, 2026 is 0.04. In the previous year, Quick Ratio (Acid Test) was 0.87 — a change of -95.63% (lower).

Quick Ratio

0.04

YoY

-95.63%

Last updated:

Quick Ratio (Acid Test) of Catheter Precision is 2025 0.04 . Quick Ratio (Acid Test) of Catheter Precision was 2024 0.87 . It decreases by -95.63% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Catheter Precision Stock analysis

What does Catheter Precision do? Ra Medical Systems, Inc. generates revenue through the sale of its electrophysiology products Amigo, VIVO, and LockeT to hospitals, physicians, and healthcare providers. The company's Amigo remote catheter system, featuring an open architecture design, allows for versatile use across multiple catheter procedures. VIVO, a non-invasive 3D imaging system, helps physicians identify arrhythmia origins pre-procedure, improving workflow efficiency. LockeT, a suture retention device, supports surgical procedures. These products target cardiac arrhythmia treatment, serving medical institutions and healthcare professionals seeking advanced solutions for patient care. The firm collaborates with physicians to develop and advance its electrophysiology technologies, focusing on improving cardiac arrhythmia procedures. Its product portfolio addresses the need for streamlined workflows and reduced procedure times in electrophysiology settings. Hospitals and physicians purchase these solutions to enhance patient outcomes and operational efficiency in treating vascular immune-mediated inflammatory diseases. The company's commercialization strategy centers on delivering innovative technologies that meet evolving clinical demands in cardiology. Ra Medical Systems, Inc. is engaged in providing new solutions to the market for cardiac arrhythmia treatment, emphasizing technology development for electrophysiology procedures. Its products are designed to improve patient lives through advanced catheter-based systems and imaging solutions. The company's focus on physician collaboration ensures that its offerings align with clinical needs, driving adoption among healthcare providers specializing in cardiac care. Catheter Precision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Catheter Precision stock

Quick Ratio (Acid Test) of Catheter Precision is 0.04 in 2025.

Quick Ratio (Acid Test) of Catheter Precision changed from 0.87 to 0.04, representing a -95.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Catheter Precision since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Catheter Precision with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Catheter Precision

All Key Metrics — Catheter Precision